Skip to Main Content

Author Details

Andre Konski
Chester County Hospital
1982
182
41
Sarah J Ratcliffe (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36494031Pneumothorax Associated With Deep Inspiration Breath Holding During Radiation Therapy for Breast Cancer.Pract Radiat Oncol2023
37393743Quality-adjusted survival in women with gynecologic malignancies receiving IMRT after surgery: A Ppatient Rreported Ooutcome study of NRG oncology's RTOG 1203.Gynecol Oncol2023
37150264Sustained Preservation of Cognition and Prevention of Patient-Reported Symptoms With Hippocampal Avoidance During Whole-Brain Radiation Therapy for Brain Metastases: Final Results of NRG Oncology CC001.Int J Radiat Oncol Biol Phys2023
36549347Long-Term Update of NRG/RTOG 0522: A Randomized Phase 3 Trial of Concurrent Radiation and Cisplatin With or Without Cetuximab in Locoregionally Advanced Head and Neck Cancer.Int J Radiat Oncol Biol Phys2023
35960897Intensity-Modulated Radiation Therapy Reduces Patient-Reported Chronic Toxicity Compared With Conventional Pelvic Radiation Therapy: Updated Results of a Phase III Trial.J Clin Oncol2022
33237451Correction to: Resection of Isolated Pelvic Recurrences after Colorectal Surgery: Long-Term Results and Predictors of Improved Clinical Outcome.Ann Surg Oncol2021
34125352Correction to: Resection of Isolated Pelvic Recurrences after Colorectal Surgery: Long-Term Results and Predictors of Improved Clinical Outcome.Ann Surg Oncol2021
32058845Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001.J Clin Oncol2020
31054745ACR Appropriateness Criteria<sup>®</sup> Noninvasive Clinical Staging of Primary Lung Cancer.J Am Coll Radiol2019
31574418Pooled Analysis of external-beam RADiotherapy parameters in phase II and phase III trials in radiochemotherapy in Anal Cancer (PARADAC).Eur J Cancer2019
31445109Executive Summary of the American Radium Society Appropriate Use Criteria for Local Excision in Rectal Cancer.Int J Radiat Oncol Biol Phys2019
29331574A Medicare cost analysis of MRI- versus CT-based high-dose-rate brachytherapy of the cervix: Can MRI-based planning be less costly?Brachytherapy2018
30050797Cost effectiveness of prostate cancer radiotherapy.Transl Androl Urol2018
30202809Risk factors for late bowel and bladder toxicities in NRG Oncology prostate cancer trials of high-risk patients: A meta-analysis of physician-rated toxicities.Adv Radiat Oncol2018
30559923An Economic Analysis of Radiation Therapy Oncology Group 94-10: Cost-Efficacy of Concurrent vs. Sequential Chemoradiotherapy.J Radiat Oncol2018
27727066Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Locally Advanced Head and Neck Carcinoma: NRG Oncology Radiation Therapy Oncology Group 0522.Int J Radiat Oncol Biol Phys2017
28412775Defining Value in Radiation Oncology: Approaches to Weighing Benefits vs Costs.Oncology (Williston Park)2017
28230650ACR Appropriateness Criteria® Resectable Pancreatic Cancer.Am J Clin Oncol2017
29332448Helical Therapy is Safe for Lung Stereotactic Body Radiation Therapy Despite Limitations in Achieving Sharp Dose Gradients.Technol Cancer Res Treat2017
28830662Letting Patients Decide How to Receive Their Imaging Results; A Good Idea or a Dangerous Practice? Part 2: Counterpoint: Patients Should Not Have Unchaperoned Access to Radiology Reports.J Am Coll Radiol2017
28687830Effect of the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation Therapy for Patients With Esophageal Cancer: The NRG Oncology RTOG 0436 Phase 3 Randomized Clinical Trial.JAMA Oncol2017
27729298Final Results of NRG Oncology RTOG 0246: An Organ-Preserving Selective Resection Strategy in Esophageal Cancer Patients Treated with Definitive Chemoradiation.J Thorac Oncol2017
27006359Radiation Oncology Practice: Adjusting to a New Reimbursement Model.J Oncol Pract2016
26511494CogState computerized memory tests in patients with brain metastases: secondary endpoint results of NRG Oncology RTOG 0933.J Neurooncol2016
26581671Patterns and predictors of failure following tri-modality therapy for locally advanced esophageal cancer.Acta Oncol2016
27422109ACR Appropriateness Criteria® Borderline and Unresectable Pancreas Cancer.Oncology (Williston Park)2016
25440267Increased time from neoadjuvant chemoradiation to surgery is associated with higher pathologic complete response rates in esophageal cancer.Ann Thorac Surg2015
26371522ACR Appropriateness Criteria® Local Excision in Early Stage Rectal Cancer.Am J Clin Oncol2015
26281845ACR Appropriateness Criteria® Resectable Stomach Cancer.Oncology (Williston Park)2015
24621427Limitations of the bowel bag contouring technique in the definitive treatment of cervical cancer.Pract Radiat Oncol2014
25841508Radiotherapy and radioembolization for liver metastases.Ann Palliat Med2014
25441058Multi-institutional phase I study of low-dose ultra-fractionated radiotherapy as a chemosensitizer for gemcitabine and erlotinib in patients with locally advanced or limited metastatic pancreatic cancer.Radiother Oncol2014
25323613ACR Appropriateness Criteria® rectal cancer: metastatic disease at presentation.Oncology (Williston Park)2014
25349290Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial.J Clin Oncol2014
24983373Phase I study of capecitabine combined with radioembolization using yttrium-90 resin microspheres (SIR-Spheres) in patients with advanced cancer.Br J Cancer2014
25022451Systematic review of the cost effectiveness of radiation therapy for prostate cancer from 2003 to 2013.Appl Health Econ Health Policy2014
25154822Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522.J Clin Oncol2014
24778402Reply to M.J. Brenner et al and I.R. Vogelius et al.J Clin Oncol2014
24732058Inadvertent high-dose therapy with temozolomide in a child with recurrent pontine glioma followed by a rapid clinical response but deteriorated after substitution with low-dose therapy.J Pediatr Hematol Oncol2014
24909911Radiosensitization of pancreatic cancer cells by metformin through the AMPK pathway.Radiat Res2014
24558509ACR Appropriateness Criteria®-Anal Cancer.Gastrointest Cancer Res2014
23167547ACR Appropriateness Criteria ® spinal bone metastases.J Palliat Med2013
24674412Women at increased risk for cardiac toxicity following chemoradiation therapy for esophageal carcinoma.Pract Radiat Oncol2013
24077456Radioprotection of lung tissue by soy isoflavones.J Thorac Oncol2013
24101042Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer.J Clin Oncol2013
23870233Gamma Knife radiosurgery in the management of brainstem metastases.Clin Neurol Neurosurg2013
23835374Lung SBRT: dosimetric and delivery comparison of RapidArc, TomoTherapy, and IMR.J Appl Clin Med Phys2013
24021346Differential effect of soy isoflavones in enhancing high intensity radiotherapy and protecting lung tissue in a pre-clinical model of lung carcinoma.Radiother Oncol2013
23781699Is hypofractionation the solution? The financial implications of breast cancer treatments.Oncology (Williston Park)2013
23519570Comparing cost-effectiveness analyses of denosumab versus zoledronic acid for the treatment of bone metastases.Support Care Cancer2013
  • 1 - 50 of 182

Recommended Authors

Rush University Medical Center
Career Start Year 2013
Number of shared co-authors 8
Western University and London Regional Cancer Program
Career Start Year 2013
Number of shared co-authors 2
University Hospitals Seidman Cancer Centre, Cleveland Medical Centre
Career Start Year 2012
Number of shared co-authors 12
Princess Margaret Cancer Centre
Career Start Year 2010
Number of shared co-authors 2
Duke University School of Medicine
Career Start Year 2006
Number of shared co-authors 7
Taussig Cancer Institute, Cleveland Clinic
Career Start Year 2006
Number of shared co-authors 9
Ascension Providence Hospital
Career Start Year 2005
Number of shared co-authors 4
University of California Los Angeles
Career Start Year 2003
Number of shared co-authors 8
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2002
Number of shared co-authors 2
Memorial Sloan Kettering Cancer Center
Career Start Year 2001
Number of shared co-authors 7
University Hospitals Bristol and Weston NHS Foundation Trust
Career Start Year 2001
Number of shared co-authors 3
Juravinski Hospital and Cancer Centre, Escarpment Cancer Research Institute
Career Start Year 2001
Number of shared co-authors 5
Abramson Cancer Center, University of Pennsylvania
Career Start Year 2001
Number of shared co-authors 9
Cleveland Clinic
Career Start Year 2000
Number of shared co-authors 6
University of California Los Angeles
Career Start Year 2000
Number of shared co-authors 7
Thomas Jefferson University Hospital
Career Start Year 1999
Number of shared co-authors 10
University of Chicago
Career Start Year 1997
Number of shared co-authors 6
The Royal Marsden NHS Foundation Trust and Institute of Cancer Research
Career Start Year 1996
Number of shared co-authors 3
Huntsman Cancer Institute, University of Utah
Career Start Year 1994
Number of shared co-authors 8
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1993
Number of shared co-authors 3
Department of Radiation Oncology University of Cincinnati Cincinnati Ohio USA.
Career Start Year 1992
Number of shared co-authors 2
Maastricht University
Career Start Year 1992
Number of shared co-authors 5
Mayo Clinic
Career Start Year 1992
Number of shared co-authors 19
Johns Hopkins University School of Medicine
Career Start Year 1991
Number of shared co-authors 8
Sir Charles Gairdner Hospital
Career Start Year 1990
Number of shared co-authors 8
Duke University Medical Center
Career Start Year 1988
Number of shared co-authors 11
Universita Cattolica del Sacro Cuore
Career Start Year 1983
Number of shared co-authors 4
Massachusetts General Hospital
Career Start Year 1982
Number of shared co-authors 3
University of Newcastle
Career Start Year 1980
Number of shared co-authors 9
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Career Start Year 1976
Number of shared co-authors 23

Collaborators

Emory University, USA Winship Cancer Institute, USA School of Medicine
Co-authored papers 28
University of Miami Miller School of Medicine
Co-authored papers 12
Stanford University
Co-authored papers 10
Proton Therapy Center- Northwestern University
Co-authored papers 10
University of California San Francisco
Co-authored papers 9
Fox Chase Cancer Center
Co-authored papers 8
Virginia Tech
Co-authored papers 8
Mount Sinai Hospital
Co-authored papers 8
University of North Carolina
Co-authored papers 7
University of Toronto
Co-authored papers 6
Oregon Health & Science University
Co-authored papers 6
Co-authored papers 5
Northwestern University Feinberg School of Medicine
Co-authored papers 5
Salem Regional Medical Center
Co-authored papers 5
Mayo Clinic
Co-authored papers 4
Taussig Cancer Institute, Cleveland Clinic
Co-authored papers 4
Memorial Sloan Kettering Cancer Center
Co-authored papers 4
Prostate Cancer Center of New Jersey.
Co-authored papers 4
Co-authored papers 4
Sutter Medical Center Sacramento
Co-authored papers 4
MD Anderson Cancer Center
Co-authored papers 3
MD Anderson Cancer Center
Co-authored papers 3
Institute on Health and Aging, University of California san francisco
Co-authored papers 3
University of California los angeles
Co-authored papers 3
Thomas Jefferson University
Co-authored papers 2
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Juravinski Cancer Centre
Co-authored papers 2
Pamela Youde Nethersole Eastern Hospital
Co-authored papers 2
University of Virginia
Co-authored papers 2
Western University and London Regional Cancer Program
Co-authored papers 2